Condition
Resectable Pancreatic Cancer clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Resectable Pancreatic Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Denmark (1), South Korea (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Resectable Pancreatic Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting pancreatic fistula after pancreaticoduodenectomy | — | Minya | Recruiting | Jun 15, 2025 |
| Using blood tests to predict outcomes in patients with localized pancreatic cancer | — | Aalborg and 4 other locations | Recruiting | Mar 29, 2023 |
| Combining NovoTTF-200T(P) with Gemcitabine and Nab-Paclitaxel for Treating Resectable Pancreatic Cancer | Phase 2 | Columbus, Ohio | Recruiting | Nov 22, 2022 |
| Comparing chemotherapy before and after surgery for pancreatic cancer | Phase 3 | Seoul and 1 other locations | Recruiting | Sep 7, 2022 |
| Combining chemotherapy and radiation before surgery for localized pancreatic cancer | Phase 2 | Loma Linda, California | Recruiting | Apr 10, 2018 |
All recruiting trials (5)
-
Predicting pancreatic fistula after pancreaticoduodenectomy
This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.
-
Using blood tests to predict outcomes in patients with localized pancreatic cancer
This study is testing if blood tests that look for specific DNA can help predict how well patients with localized pancreatic cancer will do after surgery and improve their follow-up care.
-
Combining NovoTTF-200T(P) with Gemcitabine and Nab-Paclitaxel for Treating Resectable Pancreatic Cancer
This study is testing if a new treatment combining NovoTTF-200T(P) with two chemotherapy drugs can help people with resectable pancreatic cancer do better and have successful surgery.
-
Comparing chemotherapy before and after surgery for pancreatic cancer
This study is testing whether giving chemotherapy before surgery can help people with resectable pancreatic cancer do better and live longer, especially in Asian patients.
-
Combining chemotherapy and radiation before surgery for localized pancreatic cancer
This study is testing if giving chemotherapy and radiation before surgery can help people with localized pancreatic cancer have better chances of completely removing the cancer.
Related topics
Quick answers
How many Resectable Pancreatic Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Denmark (1 trial), South Korea (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.